Trade

with

Sophiris Bio Inc
(NASDAQ: SPHS)
AdChoices
2.89
-0.20
-6.53%
After Hours :
-
-
-

Open

2.90

Previous Close

3.09

Volume (Avg)

15.84k (25.23k)

Day's Range

2.86-3.02

52Wk Range

2.10-5.18

Market Cap.

48.68M

Dividend Rate ( Yield )

-

Beta

1.14

Shares Outstanding

16.84M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Drug Manufacturers – Specific & Generic
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 5.00M

    • Net Income

    • -11.15M

    • Market Cap.

    • 48.68M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.14

    • Forward P/E

    • -

    • Price/Sales

    • -

    • Price/Book Value

    • 1.92

    • Price/Cash flow

    • -1.85

      • EBITDA

      • -9.26M

      • Return on Capital %

      • -113.82

      • Return on Equity %

      • -254.30

      • Return on Assets %

      • -113.82

      • Book Value/Share

      • 1.61

      • Shares Outstanding

      • 16.84M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • 12.00

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 0.00

          • 7.67

          • Net Income

            YTD/YTD (last year)

          • -

          • -26.33

          • Net Income

            Q/Q (last year)

          • -

          • 197.54

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • -5.42

          • Net Income

            5-Year Annual Average

          • -

          • 3.16

          • Dividends

            5-Year Annual Average

          • -

          • -0.13

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • -

            • 64.72

            • Pre-Tax Margin

            • -

            • 13.77

            • Net Profit Margin

            • -

            • 10.84

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 67.80

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 15.58

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 343.47B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.22

              • 0.33

              • Current Ratio

              • 6.94

              • 1.52

              • Quick Ratio

              • 6.40

              • 0.87

              • Interest Coverage

              • -26.44

              • 6.77

              • Leverage Ratio

              • 1.42

              • 1.91

              • Book Value/Share

              • 1.61

              • 16.21

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -1.77

                • 63.69

                • P/E Ratio 5-Year High

                • -17.31

                • 237.47

                • P/E Ratio 5-Year Low

                • -1.20

                • 19.71

                • Price/Sales Ratio

                • -

                • 3.64

                • Price/Book Value

                • 1.92

                • 3.39

                • Price/Cash Flow Ratio

                • -1.85

                • 21.79

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -254.30

                    (-566.80)

                  • 7.86

                    (9.58)

                  • Return on Assets %

                    (5-Year Average)

                  • -113.82

                    (-88.70)

                  • 4.14

                    (5.54)

                  • Return on Capital %

                    (5-Year Average)

                  • -139.79

                    (-121.80)

                  • 5.59

                    (7.66)

                  • Income/Employee

                  • -

                  • 27.79k

                  • Inventory Turnover

                  • -

                  • 1.80

                  • Asset Turnover

                  • -

                  • 0.38

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -9.79M
                  Operating Margin
                  -195.80
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -1.85
                  Ownership

                  Institutional Ownership

                  67.61%

                  Top 10 Institutions

                  96.85%

                  Mutual Fund Ownership

                  19.55%

                  Float

                  72.62%

                  5% / Insider Ownership

                  0.09%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Fidelity® Select Biotechnology Portfolio

                  •  

                    1,277,815

                  • 0.00

                  • 7.64

                  • T. Rowe Price Health Sciences Fund

                  •  

                    1,169,000

                  • -9.16

                  • 6.94

                  • Franklin Biotechnology Discovery

                  •  

                    287,400

                  • 0.00

                  • 1.77

                  • Fidelity Advisor® Biotechnology Fund

                  •  

                    141,653

                  • 0.00

                  • 0.85

                  • JHancock2 Health Sciences Fund

                  •  

                    87,400

                  • 0.00

                  • 0.52

                  • VALIC Company I Health Sciences Fund

                  •  

                    71,200

                  • 0.00

                  • 0.43

                  • TD Health Sciences Fund

                  •  

                    58,850

                  • 0.00

                  • 0.35

                  • FCP OP MEDICAL BioHealthTrends

                  •  

                    58,061

                  • 0.00

                  • 0.35

                  • T. Rowe Price Health Sciences Port

                  •  

                    49,300

                  • -2.75

                  • 0.29

                  • JHVIT Health Sciences Trust

                  •  

                    38,100

                  • 0.00

                  • 0.23

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Warburg Pincus & CO

                  •  

                    66,666,666

                  • 0.00%

                  • 40.70

                  • T. Rowe Price Associates, Inc.

                  •  

                    1,613,328

                  • -0.06%

                  • 9.58

                  • Great Point Partners LLC

                  •  

                    1,585,500

                  • +5.70%

                  • 9.41

                  • Artal Group S A

                  •  

                    1,000,000

                  • 0.00%

                  • 5.94

                  • First Manhattan Company

                  •  

                    605,142

                  • -19.51%

                  • 3.59

                  • Bvf Inc

                  •  

                    600,000

                  • 0.00%

                  • 3.56

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Drug Manufacturers – Specific & Generic

                  Type

                  Distressed

                  Style

                  Small Value

                  Sophiris Bio Inc is a clinical-stage biopharmaceutical company. The Company is engaged in research and development of products for the treatment of urological diseases. It is currently developing PRX302 for treatment of benign prostatic hyperplasia.

                  Key People

                  Randall E. Woods

                  CEO/Director/President

                  Dr. Lars Ekman M.D.,PhD

                  Chairman of the Board/Director

                  Peter T. Slover

                  CFO

                  Gerald T. Proehl

                  Director

                  Joseph L. Turner

                  Director

                  • Sophiris Bio Inc

                  • 1258 Prospect Street

                  • La Jolla, CA 92037

                  • CAN.Map

                  • Phone: +1 858 777-1760

                  • Fax: -

                  • sophirisbio.com

                  Incorporated

                  2002

                  Employees

                  8

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: